Dapamac M 5mg/500mg Tablet ER
Marketer
Macleods Pharmaceuticals Pvt Ltd
Salt Composition
Dapagliflozin (5mg) + Metformin (500mg)
Overview Dapamac M 5mg/500mg Tablet ER
Dapamac M 5mg/500mg Extended-Release tablets combine two medications to manage type 2 diabetes. This dual-action therapy effectively lowers elevated blood glucose, mitigating the risk of severe diabetic complications and contributing to heart health protection. Dapamac M can be ingested with meals and should be taken consistently at the same time daily for optimal adherence. Dosage is determined by your physician; discontinuation requires their approval to avoid potentially dangerous blood sugar spikes and complications such as kidney impairment and vision loss. This medication complements a comprehensive diabetes management plan, encompassing dietary adjustments, regular physical activity, and weight management as directed by your doctor. Commonly reported side effects include upper respiratory symptoms (sore throat, nasal congestion, rhinorrhea), headache, gastrointestinal upset (nausea, vomiting, diarrhea), and dehydration, which can be lessened by adequate hydration. Genital fungal infections are a possibility; good hygiene practices minimize this risk. Prior to commencing treatment, disclose any existing kidney or liver disease, urinary tract infections, or diuretic use to your doctor. Pregnant or lactating individuals should consult their physician before use. Limit alcohol consumption during treatment to reduce the potential for adverse reactions. Regular blood glucose monitoring is essential while using this medication.
Uses of Dapamac M 5mg/500mg Tablet ER
Managing Type 2 diabetes
Major Benefits of Dapamac M 5mg/500mg Tablet ER:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Dapamac M 5mg/500mg Extended-Release Tablet with a meal.
Common Side effects of Dapamac M 5mg/500mg Tablet ER:
- Nausea
- Vomiting
- Diarrhea
- Genital fungal infection
- Nasopharyngitis (inflammation of the throat and nasal passages)
- Urinary tract infection
- Polyuria
- Flatulence
- Skin rash
- Taste change
- Difficulty in urination
- Hypoglycemia (low blood glucose level)
- Tremors
- Dizziness
- Back pain
- Increased hematocrit
- Decreased creatinine clearance
- Dyslipidemia
How to use Dapamac M 5mg/500mg Tablet ER:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Dapamac M 5mg/500mg Extended-Release tablet whole; avoid crushing, chewing, or breaking it. Administer this medication with a meal.
How Dapamac M 5mg/500mg Tablet ER works:
Dapagliflozin and Metformin, combined as Dapamac M 5mg/500mg Extended-Release tablets, offer enhanced blood glucose management. Dapagliflozin facilitates urinary glucose excretion, while Metformin reduces hepatic glucose production, slows intestinal glucose uptake, and improves insulin responsiveness. This dual-action approach optimizes blood sugar control.
SAFETY ADVICE
AlcoholUNSAFE
Combining Dapamac M 5mg/500mg ER tablets with alcohol is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The extended-release Dapamac M 5mg/500mg tablet may pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible risks prior to prescription. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Extended-release Dapamac M 5mg/500mg tablets are likely unsafe for breastfeeding mothers. Available human data indicate potential transfer to breast milk, posing a risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyCAUTION
The extended-release Dapamac M 5mg/500mg tablet requires careful administration for individuals with impaired kidney function. Dosage modification of Dapamac M 5mg/500mg ER tablets may be necessary. Physician consultation is advised.
LiverCAUTION
Individuals with hepatic impairment should exercise caution when using Dapamac M 5mg/500mg Extended-Release tablets. Dosage modification of Dapamac M 5mg/500mg Extended-Release tablets may be necessary. Physician consultation is advised.
What if you forget to take Dapamac M 5mg/500mg Tablet ER :
Should you forget to take your Dapamac M 5mg/500mg Extended-Release tablet, ingest it immediately upon remembering. However, if your next scheduled dose is imminent, omit the missed dose and resume your usual medication routine. Never take a double dose.
Facts to Know About Dapamac M 5mg/500mg Tablet ER
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |



